Lantern Pharma Inc
(LTRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,012 | -1,311 | -477 | -2,428 | -1,753 |
| Depreciation Amortization | 2 | 1 | 1 | 2 | 1 |
| Other Working Capital | -1,241 | -8 | -245 | 181 | 279 |
| Other Operating Activity | 167 | 124 | 19 | 118 | 54 |
| Operating Cash Flow | $-4,084 | $-1,194 | $-703 | $-2,128 | $-1,419 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -8 | N/A | -6 | -6 |
| Investing Cash Flow | $-11 | $-8 | $N/A | $-6 | $-6 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 169 | 169 | 66 | N/A | N/A |
| Debt Issued | 109 | 109 | N/A | N/A | N/A |
| Common Stock Issued | 26,302 | 26,302 | 52 | N/A | 2,921 |
| Other Financing Activity | -2,914 | -2,811 | -13 | 2,921 | 0 |
| Financing Cash Flow | $23,665 | $23,768 | $105 | $2,921 | $2,921 |
| Beginning Cash Position | 1,232 | 1,232 | 1,232 | 445 | 445 |
| End Cash Position | 20,803 | 23,798 | 634 | 1,232 | 1,941 |
| Net Cash Flow | $19,571 | $22,566 | $-598 | $787 | $1,496 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,084 | -1,194 | -703 | -2,128 | -1,419 |
| Capital Expenditure | -11 | -8 | N/A | N/A | -6 |
| Free Cash Flow | -4,095 | -1,202 | -703 | -2,128 | -1,425 |